Source:http://linkedlifedata.com/resource/pubmed/id/12117227
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0004083,
umls-concept:C0006644,
umls-concept:C0032105,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0040300,
umls-concept:C0043481,
umls-concept:C0086045,
umls-concept:C0205195,
umls-concept:C0231441,
umls-concept:C0366376,
umls-concept:C0373748,
umls-concept:C0443218,
umls-concept:C2827483
|
pubmed:issue |
1-3
|
pubmed:dateCreated |
2002-7-15
|
pubmed:abstractText |
Because caffeine and tissue levels of Zn are closely related, the objectives of this study were to determine the changes in plasma caffeine levels over a period of 5 h when different concentrations of Zn combined with a fixed concentration of caffeine were injected into the femoral vein of rats and to determine the relationship between tissue levels of caffeine and Zn at 5 h postinjection. Rats were divided into three groups: group 1, 220 microg caffeine; group 2, 220 microg caffeine + 8 microg Zn/g body weight (BW); group 3, 220 microg caffeine + 16 microg Zn/g BW. Blood from groups 1 and 3 was collected at 3 min, 30 min, 1 h, 3 h, and 5 h to determine the pharmacokinetics of caffeine. All groups were killed at 5 h. Caffeine and Zn concentrations of the brain, kidney, heart, and liver of all groups were determined. The plasma-caffeine curve in group 3 showed a lower concentration at 3 min and a slower caffeine-elimination rate during the first 3 h. Brain and kidney caffeine levels remained constant in all groups, whereas caffeine levels were increased in the heart in group 2 and in the liver in group 3. Zn concentrations in the brain and kidney were lower in group 2 compared with groups 1 and 3 and higher in group 3 compared to groups 1 and 2. Zn concentration in the heart was the same among the three groups but was increased in the liver in group 3 compared to groups 1 and 2. Therefore, we concluded that caffeine combined with Zn affects caffeine pharmacokinetics. With caffeine intake, levels of Zn (16 microg/g BW) that are slightly higher than the daily requirements (12 microg/g BW) may prevent a reduction of Zn in tissue. In addition, caffeine's effects on Zn concentration among organs are different.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0163-4984
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
87
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
183-90
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12117227-Animals,
pubmed-meshheading:12117227-Brain,
pubmed-meshheading:12117227-Caffeine,
pubmed-meshheading:12117227-Female,
pubmed-meshheading:12117227-Kidney,
pubmed-meshheading:12117227-Myocardium,
pubmed-meshheading:12117227-Rats,
pubmed-meshheading:12117227-Rats, Sprague-Dawley,
pubmed-meshheading:12117227-Spectrophotometry, Atomic,
pubmed-meshheading:12117227-Tissue Distribution,
pubmed-meshheading:12117227-Zinc
|
pubmed:year |
2002
|
pubmed:articleTitle |
Association of different zinc concentrations combined with a fixed caffeine dose on plasma and tissue caffeine and zinc levels in the rat.
|
pubmed:affiliation |
Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans 70119, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|